The overall objective of the proposed research is to elucidate and counter inefficiencies in fatty acid and carbohydrate metabolism for energy production, imposed by compensatory recruitment of alternative pathways and altered metabolic gene expression in pressure overloaded hearts.
Aims are intended to yield new metabolic strategies to mitigate the development of cardiomyopathy leading to overt heart failure. Ongoing work has elucidated 1) increased NADPH-dependent malic enzyme (ME) expression in cardiac hypertrophy that increases anaplerotic flux into the second span of the TCA cycle and may impact on regulation of fatty acid oxidation and storage, with apparent effects on contractility;2) increased expression of the liver (L) isoform of carnitine palmitoyltransferase I (L-CPT1) in hypertrophied hearts that coincides with reduced fatty acid oxidation;3) large reductions in both content and turnover rates of the triacylglyceride (TAG) pool in hypertrophied hearts that coincide with a loss of the contribution from TAG to fatty acid oxidation. Based on these key findings of the current funding period, experiments test the hypothesis that normal TAG content and turnover are required to maintain baseline lipolytic contributions to fatty acid oxidation, which is critical to the flexibility of the metabolic support of contractility, and that dysregulation of lipid storage dynamics in cardiac hypertrophy, in part, due to maladaptive shifts in anaplerosis via malic enzyme and fatty acid oxidation via L- CPT1, affects the metabolic efficiency of contraction. The hypothesis will be tested using dynamic-mode 13C NMR of genetically altered rat hearts and transgenic mouse hearts with pressure overload hypertrophy.
Aim 1 investigates the effects of increased ME expression on both triglyceride dynamics and redox regulation in hypertrophied rat hearts using adenoviral-based ME overexpression in normal hearts and RNA suppression of ME in hypertrophy.
This aim also tests the effects of fatty acid chain length and dietary fat on TAG dynamics in cardiac hypertrophy and the metabolic fate of pyruvate due to differential ME expression.
Aim 2 tests the functional significance of increased L-CPT1 expression on the reciprocal activity and balance between fatty acid storage kinetics and oxidation in hypertrophied rat hearts using L-CPT1 RNA inhibition.
Aim 3 explores the influences of augmented fatty acid uptake and PPAR1 expression on the changes in TAG dynamics and oxidation in hypertrophied hearts of transgenic mice with either fatty acid transporter 1 (FATP1) overexpression or low overexpression of PPAR1. Rather than investigate a single enzyme, we propose an integrative approach to investigate potentially maladaptive changes in metabolic enzyme expression in cardiac hypertrophy, while exploring the potential mechanisms for, and functional significance of reduced TAG dynamics in hypertrophy. The anticipated findings will contribute a basic, mechanistic understanding to a topical problem of clinical importance, which is the link between dysregulation of cardiac lipid dynamics and contractile dysfunction in the pathogenesis of decompensated hypertrophy.

Public Health Relevance

The specific focus of this research are mechanisms of altered fatty acid oxidation and storage by the heart, that are linked to unexplained upregulation of enzymes for fatty acid oxidation and alternative pathways of carbohydrate metabolism in the hypertrophied heart, that were first identified by the PI during the previous funding period. Importantly, our findings indicate that these metabolic changes appear to be reversible in experimental models of cardiac hypertrophy with direct effects on the contractile function of the heart. The relationship of myocardial lipid content and dynamics to cardiac dysfunction in pressure overload hypertrophy will be examined in isolated hearts from rat models of pressure overload hypertrophy and exogenous gene delivery and transgenic mouse models of augmented, cardiac fatty acid uptake and metabolism. We will apply novel observations of metabolic flux in the intact, beating rat heart via NMR and improved cardiac gene delivery schemes, to both monitor and intervene in the development of potentially maladaptive, alterations that occur in the energy yielding, metabolic pathways of the hypertrophied heart. Therefore, this research is intended to elucidate mechanisms of impaired lipid metabolism in hypertrophied hearts that directly related to impaired cardiac function and the development of decompensated hypertrophy, and to test potentially therapeutic interventions of the metabolic processes contributing to such dysfunction.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Myocardial Ischemia and Metabolism Study Section (MIM)
Program Officer
Danthi, Narasimhan
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Illinois at Chicago
Schools of Medicine
United States
Zip Code
Aubert, Gregory; Martin, Ola J; Horton, Julie L et al. (2016) The Failing Heart Relies on Ketone Bodies as a Fuel. Circulation 133:698-705
Banke, Natasha H; Lewandowski, E Douglas (2015) Impaired cytosolic NADH shuttling and elevated UCP3 contribute to inefficient citric acid cycle flux support of postischemic cardiac work in diabetic hearts. J Mol Cell Cardiol 79:13-20
O'Donnell, J Michael; Fasano, Matthew J; Lewandowski, E Douglas (2015) Resolving confounding enrichment kinetics due to overlapping resonance signals from 13C-enriched long chain fatty acid oxidation and uptake within intact hearts. Magn Reson Med 74:330-5
Carley, Andrew N; Taglieri, Domenico M; Bi, Jian et al. (2015) Metabolic efficiency promotes protection from pressure overload in hearts expressing slow skeletal troponin I. Circ Heart Fail 8:119-27
Lahey, Ryan; Wang, Xuerong; Carley, Andrew N et al. (2014) Dietary fat supply to failing hearts determines dynamic lipid signaling for nuclear receptor activation and oxidation of stored triglyceride. Circulation 130:1790-9
Carley, Andrew N; Bi, Jian; Wang, Xuerong et al. (2013) Multiphasic triacylglycerol dynamics in the intact heart during acute in vivo overexpression of CD36. J Lipid Res 54:97-106
Lewandowski, E Douglas; Fischer, Susan K; Fasano, Matthew et al. (2013) Acute liver carnitine palmitoyltransferase I overexpression recapitulates reduced palmitate oxidation of cardiac hypertrophy. Circ Res 112:57-65
O'Donnell, J Michael; Kalichira, Asha; Bi, Jian et al. (2012) In vivo, cardiac-specific knockdown of a target protein, malic enzyme-1, in rat via adenoviral delivery of DNA for non-native miRNA. Curr Gene Ther 12:454-62
Pound, Kayla M; Arteaga, Grace M; Fasano, Mathew et al. (2011) Expression of slow skeletal TnI in adult mouse hearts confers metabolic protection to ischemia. J Mol Cell Cardiol 51:236-43
Banke, Natasha H; Wende, Adam R; Leone, Teresa C et al. (2010) Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPARalpha. Circ Res 107:233-41

Showing the most recent 10 out of 25 publications